Alfa Laval AB (publ) Interim report April 1 - June 30, 2014

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 17, 2014 at 2:45 AM

“The order intake increased with 19 percent and reached a record level during the second quarter of the year, driven by a broad increase in demand for all three divisions. The recently acquired Frank Mohn AS, that is consolidated as per May 22, added SEK 0.6 billion. In total, the order intake was SEK 9.0 billion. Process Technology saw a sequential upturn, driven by a very strong development for the base business. At the same time, the order intake for Marine & Diesel increased substantially, also excluding Frank Mohn AS, among other things due to a strong demand for boilers, that resulted in several larger orders during the quarter. Equipment saw a seasonally positive development and a strong demand from the food and beverage industry. In the Central and Eastern Europe region a broad and strong increase in demand was seen. A contributing factor to the positive development was Russia, that recovered from a weak first quarter with increases within the base as well as the project business. The same factors were behind the upturns in Western Europe, North America and Asia, where the strong development in China was generated by all three divisions.” Lars Renström, President and CEO Summary: second quarter Order intake increased by 18 percent** to SEK 8,969 (7,524) million. Net sales increased by 12 percent** to SEK 8,423 (7,515) million. Adjusted EBITA was SEK 1,348 (1,237) million. Adjusted EBITA margin was 16.0 (16.5) percent. Result after financial items was SEK 1,159 (969) million. Net income was SEK 796 (644) million. Earnings per share was SEK 1.89 (1.53). Cash flow from operating activities was SEK 1,174 (1,038) million. Impact on EBITA of foreign exchange effects was SEK -10 (-63) million. Impact on result after financial items of comparison distortion items was SEK - (-) million. Summary: first six months Order intake increased by 12 percent** to SEK 16,443 (14,654) million. Net sales increased by 7 percent** to SEK 15,020 (14,020) million. Adjusted EBITA was SEK 2,410 (2,304) million. Adjusted EBITA margin was 16.0 (16.4) percent. Result after financial items was SEK 1,953 (1,896) million. Net income was SEK 1,360 (1,347) million. Earnings per share was SEK 3.23 (3.20). Cash flow from operating activities was SEK 1,766 (2,009) million. Impact on EBITA of foreign exchange effects was SEK ‑20 (‑95) million. Impact on result after financial items of comparison distortion items was SEK -60 (-) million. * 2013 restated to IFRS 11. ** Excluding currency effects. Outlook for the third quarter “We expect that demand during the third quarter 2014 will be on about the same level as in the second quarter.”´ Earlier published outlook (April 28, 2014): “We expect that demand during the second quarter 2014 will be on about the same level as in the first quarter.” The interim report has not been subject to review by the company’s auditors. For more information, please contact: Peter Torstensson, Senior Vice President, Communications Phone: +46 46 36 72 31 (http://connect.ne.cision.com) Mobile: +46 709 33 72 31 (http://connect.ne.cision.com) peter.torstensson@alfalaval.com Gabriella Grotte, Investor Relations Manager Phone: +46 46 36 74 82 (http://connect.ne.cision.com) Mobile: +46 709 78 74 82 (http://connect.ne.cision.com) gabriella.grotte@alfalaval.com Alfa Laval AB (publ) PO Box 73 SE-221 00 Lund Sweden Corporate registration number: 556587-8054 Alfa Laval AB (publ) discloses the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 08.30 CET on July 17, 2014.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

D-Wave Quantum Hit with Securities Fraud Lawsuit

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Employment Law Suit Hits ABC: Alleged Wage Violations

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Championing Change: USTA Mid-Atlantic Gala's Impact

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Viking Ventures: Impacts of VK2735 on Obesity Examined

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...